Palvella Therapeutics PVLA Ratios & Valuation
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| Liquidity | ||||||
| Current ratio | 28.9×+23.7× | 5.2×-1.3× | 6.5×— | —— | —— | |
| Per Share | ||||||
| Book value per share | $17.75+614% | $2.49-28.9% | $3.50-19.1% | $4.32-14.3% | $5.05-82.1% | |
| Valuation | ||||||
| Market capitalization | $1.78B+44.0% | $1.24B+78.7% | $693.33M— | —— | —— | |
| Price / book | 7.7×-36.6× | 44.3×+26.4× | 17.9×— | —— | —— |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- Where do Palvella Therapeutics's ratios come from?
- Every ratio is computed from Palvella Therapeutics's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.